Research is a major component of the NH Blood and Marrow Transplant, Leukemia and Immunotherapy programs. The high quality of our research program is demonstrated by NH-BMT, one of twenty national BMT Programs and Program Consortia, selected as a Core Clinical Center for the Blood and Marrow Transplant Clinical Trials Network (BMT-CTN). NH-BMT joins only 19 other elite BMT Programs (and is the only one in the state of Georgia) in becoming a primary recipient of this competitive award and status.

The Leukemia & Lymphoma Society (LLS) and the Dana-Farber Cancer Institute has established a network of sites for clinical trial testing of innovative blood cancer therapies in community oncology settings across the country. This groundbreaking Blood Cancer Research Partnership (BCRP),, will bring clinical trials closer to where patients live and help to address one of the primary bottlenecks in the development of new cancer therapies: the need for more patients to take part in trials. NH-BMT is one of ten sites who have been selected to participate in this prestigious partnership. Please review Cooperative Groups.

Our experienced research team includes research nurses, pharmacists experienced in the handling of investigational agents, and laboratory personnel.

At NH-BMT your BMTGA physicians and clinical research team will offer you possible treatment option(s) including both standard of care treatment as well as potential clinical trials, providing you with the information you need to make an informed decision. To help you and your family understand what is involved in a clinical trial, the following information is available for your review, What is a Clinical Trial?

Dr. Asad Bashey, Northside’s Clinical Research Medical Director from Northside Hospital on Vimeo.

Important facts to know about clinical research:

  • The goal of clinical research trials is to determine the safety and efficacy of new drugs which will hopefully improve survival and quality of life.
  • Participation in a clinical trial may offer you access to a new therapy for your disease which is not otherwise available, or the use of an established treatment in a new setting.
  • Your participation in clinical trials is completely voluntary.
  • When new clinical trial information is available, you will be informed by your BMT physician